FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:963-964 April 6, 1995 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Angell, M. Related Article by Keeney, R. L.

To the Editor: With respect to Angell and Kassirer's editorial (July 21 issue)¹ concerning the public's confusion about the results of clinical trials, I think the public and the media would be better able to assess research results if medical researchers themselves were more modest and careful when discussing their results with journalists. The Journal has led the way in embargoing research results until after publication, but such rules cannot prevent the ambitious or naive investigator (or the investigator's institution) from touting results and pushing conclusions beyond the limits of the data. This problem is likely to increase as corporate . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.